
AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Mosaic, you have to believe fertilizer demand and disciplined capital returns can offset commodity cyclicality and rising input costs. The latest earnings miss and analyst downgrades sharpen the near term focus on margin pressure from sulfur and ammonia, which now looks like the key short term catalyst and risk: any relief in input costs or improvement in volumes could quickly change sentiment, while persistent inflation in raw materials could keep expectations subdued.
Against this backdrop, the progress of Mosaic’s Brazilian rare earths joint venture into prefeasibility, with construction targeted for 2027, stands out. It highlights a potential future earnings stream that is less tied to traditional phosphate and potash cycles, but it is still early stage and does little to offset current concerns around potash oversupply and compressed phosphate margins, which remain front and center for the stock today.
Yet behind the mixed earnings and downgrades, investors should also weigh the risk that rising regulatory and environmental costs could further pressure margins and...
Read the full narrative on Mosaic (it's free!)
Mosaic's narrative projects $13.1 billion revenue and $851.3 million earnings by 2028. This requires 5.2% yearly revenue growth and a $88.7 million earnings decrease from $940.0 million today.
Uncover how Mosaic's forecasts yield a $32.17 fair value, a 21% upside to its current price.
Some of the lowest ranked analysts take a far darker view than consensus, assuming revenues of about US$11.4 billion and earnings near US$305.9 million, so it is worth weighing how the new input cost and margin pressures might push expectations closer to, or away from, that more pessimistic path.
Explore 5 other fair value estimates on Mosaic - why the stock might be worth 10% less than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com